784
Views
34
CrossRef citations to date
0
Altmetric
Biologics

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2

, , , , , , & show all
Pages 337-347 | Received 06 Jan 2010, Accepted 19 May 2010, Published online: 31 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Kristian Reich, Peter Foley, Chenglong Han, Sean McElligott, Erik Muser, Nan Li & April W. Armstrong. (2020) Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab. Journal of Dermatological Treatment 31:6, pages 617-623.
Read now
Jillian Frieder, Dario Kivelevitch, Connie Tran Fiore, Saadeddine Saad & Alan Menter. (2018) The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis. Expert Review of Clinical Immunology 14:1, pages 1-19.
Read now
E. G. Simon, S. Samuel, S. Ghosh & G. W. Moran. (2016) Ustekinumab: a novel therapeutic option in Crohn’s disease. Expert Opinion on Biological Therapy 16:8, pages 1065-1074.
Read now
Nicole C. Rouse, Michael E. Farhangian, Brooke Wehausen & Steven R. Feldman. (2015) The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 877-884.
Read now
Anne Tuskey & Brian W Behm. (2014) Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn’s disease. Clinical and Experimental Gastroenterology 7, pages 173-179.
Read now
Matthias Augustin & Marc Alexander Radtke. (2014) Quality of life in psoriasis patients. Expert Review of Pharmacoeconomics & Outcomes Research 14:4, pages 559-568.
Read now
Vicky Ren & Harry Dao$suffix/text()$suffix/text(). (2013) Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis. Clinical, Cosmetic and Investigational Dermatology 6, pages 75-80.
Read now
Atsuyuki Igarashi, Hiroyo Kuwabara, Kyle Fahrbach & Brad Schenkel. (2013) Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan. Journal of Dermatological Treatment 24:5, pages 351-355.
Read now

Articles from other publishers (26)

Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach & Laurence Le Cleach. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Wei Zhang, Paige Tocher, Jacynthe L’Heureux, Julie Sou & Huiying Sun. (2023) Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review. Value in Health 26:1, pages 123-137.
Crossref
L. Guenther, A. Takhar, M. Megna, M. Sebastian, N. Nyholm, H. Thoning & L.‐Å. Levin. (2022) Impact of fixed‐dose combination Cal/BD foam on the work productivity of patients with psoriasis: results from the 52‐week randomized, double‐blind, PSO‐LONG trial. Journal of the European Academy of Dermatology and Venereology 36:7, pages 1054-1063.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2022) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2021) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2020) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Marcelo Arnone, Maria Denise Fonseca Takahashi, André Vicente Esteves de Carvalho, Wanderley Marques Bernardo, Aline Lopes Bressan, Andrea Machado Coelho Ramos, Aripuanã Cobério Terena, Cacilda da Silva Souza, Daniel Holthausen Nunes, Maria Cecília de Carvalho Bortoletto, Maria de Fátima Santos Paim de Oliveira, Jane Marcy Neffá, Luciana Cristina Fieri, Luna Azulay-Abulafia, Paulo Antônio Oldani Felix, Renata Ferreira Magalhaes, Ricardo Romiti & Tatiana Jerez Jaime. (2019) Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia 94:2 suppl 1, pages 76-107.
Crossref
Marcelo Arnone, André Vicente Esteves de Carvalho, Maria Denise Fonseca Takahashi & Wanderley M Bernardo. (2019) Psoriasis in moderate grave plaque - immunobiological treatment. Revista da Associação Médica Brasileira 65:4, pages 493-508.
Crossref
Craig A. Elmets, Craig L. Leonardi, Dawn M.R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Dario Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin Stoff, Bruce E. Strober, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Alan Menter. (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. Journal of the American Academy of Dermatology 80:4, pages 1073-1113.
Crossref
Sahil Sekhon, Caleb Jeon & Wilson Liao. 2018. Evidence-Based Psoriasis. Evidence-Based Psoriasis 73 92 .
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi, Olivier Chosidow & Laurence Le Cleach. (2017) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
April W. Armstrong, Emily Edson-Heredia, Baojin Zhu, Enkeleida Nikaï, Orin Goldblum, Kristin Hollister, James Russell, Michael Siegel & Mark Lebwohl. (2017) Burden of Psoriasis as Reported in a Cross-Sectional Study: Association of Psoriasis Severity with Health-Related Quality of Life, Depression, and Work Productivity. Journal of Psoriasis and Psoriatic Arthritis 2:4, pages 106-112.
Crossref
M. Augustin, C. Blome, C. Paul, L. Puig, T. Luger, J. Lambert, S. Chimenti, G. Girolomoni, K. Kragballe, D. Naessens, P. Bergmans, P. Smirnov, J. Barker & K. Reich. (2017) Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis. Journal of the European Academy of Dermatology and Venereology 31:2, pages 294-303.
Crossref
Denise Küster, Alexander Nast, Sascha Gerdes, Tobias Weberschock, Gottfried Wozel, Mandy Gutknecht & Jochen Schmitt. (2016) Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting. Archives of Dermatological Research 308:4, pages 249-261.
Crossref
George E. FragoulisStefan SiebertIain B. McInnes. (2016) Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases. Annual Review of Medicine 67:1, pages 337-353.
Crossref
Ebby G. Simon, Subrata Ghosh, Marietta Iacucci & Gordon W. Moran. (2015) Ustekinumab for the treatment of Crohn’s disease: can it find its niche?. Therapeutic Advances in Gastroenterology 9:1, pages 26-36.
Crossref
Lakshi M. Aldredge & Melodie S. Young. (2016) Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy. Journal of the Dermatology Nurses' Association 8:1, pages 14-26.
Crossref
Matthias Augustin & Marc Alexander Radtke. 2016. Handbook of Psoriasis and Psoriatic Arthritis. Handbook of Psoriasis and Psoriatic Arthritis 101 116 .
Anssi Mustonen, Kalle Mattila, Mauri Leino, Leena Koulu & Risto Tuominen. (2015) How much of the productivity losses among psoriasis patients are due to psoriasis. BMC Health Services Research 15:1.
Crossref
Hee-Sun Moon, Alexandra Mizara & Sandy R. McBride. (2013) Psoriasis and Psycho-Dermatology. Dermatology and Therapy 3:2, pages 117-130.
Crossref
Kenneth Tang, Dorcas E. Beaton, Benjamin C. AmickIIIIII, Sheilah Hogg-Johnson, Pierre Côté & Patrick Loisel. (2012) Confirmatory Factor Analysis of the Work Limitations Questionnaire (WLQ-25) in Workers’ Compensation Claimants with Chronic Upper-Limb Disorders. Journal of Occupational Rehabilitation 23:2, pages 228-238.
Crossref
Georgia Avgerinou, Ioannis Bassukas, Georgios Chaidemenos, Andreas Katsampas, Marita Kosmadaki, Hara Kousoulakou, Athanasios Petridis, Brad Schenkel, Dimitrios Sotiriadis, Theofanis Spiliopoulos, Panagiotis Stavropoulos, Evgenia Toumpi & Loukas Xaplanteris. (2012) Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece. BMC Dermatology 12:1.
Crossref
Hidemi NAKAGAWA, Brad SCHENKEL, Mai KATO, Takeshi KATO & Atsuyuki IGARASHI. (2012) Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial. The Journal of Dermatology 39:9, pages 761-769.
Crossref
Francesca Sampogna & Damiano Abeni. (2012) Outcomes in Psoriasis Clinical Trials from January 2011 to March 2012. Current Dermatology Reports 1:3, pages 137-147.
Crossref
Ronald Vender, Charles Lynde, Vincent Ho, Dina Chau & Melanie Poulin-Costello. (2012) Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis. Applied Health Economics and Health Policy 10:5, pages 343-353.
Crossref
M. Augustin, J.M. Alvaro-Gracia, M. Bagot, O. Hillmann, P.C.M. van de Kerkhof, G. Kobelt, M. Maccarone, L. Naldi & H. Schellekens. (2012) A framework for improving the quality of care for people with psoriasis. Journal of the European Academy of Dermatology and Venereology 26, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.